Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Jian Li, explained in plain language.
This study is testing a new targeted drug called JAB-21822 for Chinese patients with advanced colorectal cancer that has a specific genetic change called KRAS G12C. The drug is combined with standard second-line chemotherapy and another cancer drug (bevacizumab) after initial tre…
Phase: PHASE1 • Sponsor: Jian Li • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC